Adverse Events Uncovered with New Antibiotics, Antivirals

Study Objective: To review quantitatively and qualitatively the U.S. Food and Drug Administration (FDA) Adverse Event Reporting System (AERS) database to provide clinicians with a general understanding of the comparative occurrence of clinically meaningful adverse events associated with 15 antimicrobial new molecular entities approved by the FDA since 2006.

READ FULL ARTICLE From Wiley Online Library